Trials / Not Yet Recruiting
Not Yet RecruitingNCT04777500
taVNS Treatment for Fibromyalgia
Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yard campus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Auricular transcutaneous electrical nerve stimulation device | We are investigating whether taVNS can relieve chronic pain symptoms associated with Fibromyalgia. |
Timeline
- Start date
- 2026-10-03
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2021-03-02
- Last updated
- 2026-04-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04777500. Inclusion in this directory is not an endorsement.